These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 12239179)

  • 41. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Latent HBV infection in single blood donors].
    Fedorchenko SV; Zanevskaia LI; Burma NM; Borisevich OS; Balitskaia TE; Iurchenko LF; Martynovich TL
    Vopr Virusol; 2008; 53(3):23-5. PubMed ID: 18590131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece.
    Zervou EK; Dalekos GN; Boumba DS; Tsianos EV
    Transfusion; 2001 May; 41(5):652-8. PubMed ID: 11346702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occult hepatitis B infections among blood donors in Lao PDR.
    Jutavijittum P; Andernach IE; Yousukh A; Samountry B; Samountry K; Thammavong T; Keokhamphue J; Toriyama K; Muller CP
    Vox Sang; 2014 Jan; 106(1):31-7. PubMed ID: 23931585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing.
    Miletić M; Bingulac-Popović J; Stojić Vidović M; Hećimović A; Berendika M; Babić I; Đogić V; Samardžija M; Barišić K; Jukić I; Mihaljević I
    Transfus Clin Biol; 2019 Nov; 26(4):257-262. PubMed ID: 31153786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction.
    Scully LJ; Sung H; Pennie R; Gill P
    J Med Virol; 1994 Nov; 44(3):293-7. PubMed ID: 7852973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of hepatitis B virus DNA in blood units with anti-HBc as the only positive serological marker.
    Tseliou P; Spiliotakara A; Dimitracopoulos GO; Christofidou M
    Haematologia (Budap); 2000; 30(3):159-65. PubMed ID: 11128108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML
    J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.
    El-Zaatari M; Kazma H; Naboulsi-Majzoub M; Haidar M; Ramlawi F; Mahfoud Z; Ramia S
    J Hosp Infect; 2007 Jul; 66(3):278-82. PubMed ID: 17540476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.
    Kleinman SH; Kuhns MC; Todd DS; Glynn SA; McNamara A; DiMarco A; Busch MP;
    Transfusion; 2003 Jun; 43(6):696-704. PubMed ID: 12757519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
    J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.